Director, GOG Partners

Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025

Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight

Site Engagement Liaison

The GOG Foundation, Inc is focused on enhancing clinical trial performance and patient enrollment. The Site Engagement Liaison will build relationships with clinical trial sites, advocate for participation in trials, and ensure alignment between site capabilities and trial needs.

Sign up with Google

Sign in with Google